Supplement: Introduction from James C. Greenwood

Introduction from James C. Greenwood Dear Readers: As the president and CEO of the Biotechnology Industry Organization (BIO), it is my privilege to represent an industry that is saving and improving the lives, health, and well-being of billions of people around the world. Innovative biotechnology products are transforming the fight against disease, hunger, and pollution. I am proud to be associated with the dedicated men and women who make up the biotechnology industr

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Dear Readers:

As the president and CEO of the Biotechnology Industry Organization (BIO), it is my privilege to represent an industry that is saving and improving the lives, health, and well-being of billions of people around the world. Innovative biotechnology products are transforming the fight against disease, hunger, and pollution. I am proud to be associated with the dedicated men and women who make up the biotechnology industry and who are at the forefront of creating solutions to some of our most pressing global challenges.

I am equally proud of the significant life science contributions of my hometown, the Greater Philadelphia region. Having represented parts of this region as a state and federal legislator, I have been a witness to its remarkable rise.

Our region's success is built on strong foundations, starting with world-class research universities and medical centers that provide a steady stream of innovative new ideas. In the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies